Global Neuromodulation Devices and Implantable Infusion Pumps Supply, Demand and Key Producers, 2026-2032
The global Neuromodulation Devices and Implantable Infusion Pumps market size is expected to reach $ 9058 million by 2032, rising at a market growth of 5.9% CAGR during the forecast period (2026-2032).
Neuromodulation Devices and Implantable Infusion Pumps are implantable medical systems designed to provide long-term regulation of nervous-system function through electrical stimulation or targeted drug delivery. Neuromodulation systems generally comprise an implantable pulse generator, leads, extensions, patient controllers and clinician programming platforms, and include spinal cord stimulation, deep brain stimulation, dorsal root ganglion stimulation, vagus nerve stimulation and sacral neuromodulation. Implantable infusion pumps incorporate a drug reservoir, precision pumping mechanism, catheter and programmable controller to deliver medication continuously or according to a prescribed schedule to an intrathecal or other targeted site. These products are primarily used for chronic intractable pain, movement disorders such as Parkinson?s disease, epilepsy, bladder and bowel dysfunction, cancer pain and severe spasticity. Their central value lies in delivering adjustable, reversible and durable therapy with greater anatomical precision.In 2025, global Neuromodulation Devices and Implantable Infusion Pumps production reached approximately 279.63 k units.The average gross profit margin of this product is 75%.
Population aging, the rising burden of chronic pain and neurological disease, and growing concern regarding long-term systemic medication use are creating a durable demand base. Neuromodulation can act directly on selected neural pathways and allows stimulation settings to be adjusted according to patient response, while intrathecal infusion delivers medication near the spinal cord and may support patients who receive insufficient relief or unacceptable adverse effects from oral therapy. Continued advances in stimulation waveforms, directional leads, miniaturized power systems and digital programming are expanding treatment beyond traditional refractory cases toward more precisely selected patient groups. The industry is consequently evolving from a standalone implant market into a long-term ecosystem combining implantation, programming, follow-up services and replacement components.
Because these products require surgical implantation and remain in the body for extended periods, adoption is influenced by patient selection, specialist availability, reimbursement and willingness to undergo an implant procedure. Infection, lead migration or fracture, premature battery depletion, declining therapeutic effect and discomfort at the implant site may require reprogramming, revision or additional surgery. Implantable infusion pumps introduce further risks involving catheter blockage, underdelivery or overdose, pump interruption and refill management. Rigorous regulatory review, long-term reliability testing and continuous adverse-event surveillance increase development and compliance costs, making manufacturing quality and post-market support essential to customer confidence.
Hospitals and physicians are moving beyond evaluating whether a system can generate stimulation and are focusing increasingly on whether it can provide durable, stable and manageable clinical outcomes. Demand is shifting toward smaller implants, longer operating life, lower charging burden, MRI compatibility and support for multiple therapy programs. Intelligent systems capable of sensing patient status, refining stimulation parameters and preserving treatment records will strengthen individualized care. Multidisciplinary collaboration among pain centers, neurosurgery, functional neurology, urology and rehabilitation departments is also increasing, making patient-selection support, physician training, programming services and long-term follow-up as influential as the device itself in purchasing decisions.
This report studies the global Neuromodulation Devices and Implantable Infusion Pumps production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Neuromodulation Devices and Implantable Infusion Pumps and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Neuromodulation Devices and Implantable Infusion Pumps that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Neuromodulation Devices and Implantable Infusion Pumps total production and demand, 2021-2032, (Unit)
Global Neuromodulation Devices and Implantable Infusion Pumps total production value, 2021-2032, (USD Million)
Global Neuromodulation Devices and Implantable Infusion Pumps production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Unit), (based on production site)
Global Neuromodulation Devices and Implantable Infusion Pumps consumption by region & country, CAGR, 2021-2032 & (Unit)
U.S. VS China: Neuromodulation Devices and Implantable Infusion Pumps domestic production, consumption, key domestic manufacturers and share
Global Neuromodulation Devices and Implantable Infusion Pumps production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Unit)
Global Neuromodulation Devices and Implantable Infusion Pumps production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Unit)
Global Neuromodulation Devices and Implantable Infusion Pumps production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Unit)
This report profiles key players in the global Neuromodulation Devices and Implantable Infusion Pumps market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Boston Scientific, Abbott, Nevro, LivaNova, Synapse Biomedical, Flowonix, Tricumed, PINS Medical, SceneRay, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Neuromodulation Devices and Implantable Infusion Pumps market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Unit) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Neuromodulation Devices and Implantable Infusion Pumps Market, By Region:
1. How big is the global Neuromodulation Devices and Implantable Infusion Pumps market?
2. What is the demand of the global Neuromodulation Devices and Implantable Infusion Pumps market?
3. What is the year over year growth of the global Neuromodulation Devices and Implantable Infusion Pumps market?
4. What is the production and production value of the global Neuromodulation Devices and Implantable Infusion Pumps market?
5. Who are the key producers in the global Neuromodulation Devices and Implantable Infusion Pumps market?
6. What are the growth factors driving the market demand?
Neuromodulation Devices and Implantable Infusion Pumps are implantable medical systems designed to provide long-term regulation of nervous-system function through electrical stimulation or targeted drug delivery. Neuromodulation systems generally comprise an implantable pulse generator, leads, extensions, patient controllers and clinician programming platforms, and include spinal cord stimulation, deep brain stimulation, dorsal root ganglion stimulation, vagus nerve stimulation and sacral neuromodulation. Implantable infusion pumps incorporate a drug reservoir, precision pumping mechanism, catheter and programmable controller to deliver medication continuously or according to a prescribed schedule to an intrathecal or other targeted site. These products are primarily used for chronic intractable pain, movement disorders such as Parkinson?s disease, epilepsy, bladder and bowel dysfunction, cancer pain and severe spasticity. Their central value lies in delivering adjustable, reversible and durable therapy with greater anatomical precision.In 2025, global Neuromodulation Devices and Implantable Infusion Pumps production reached approximately 279.63 k units.The average gross profit margin of this product is 75%.
Population aging, the rising burden of chronic pain and neurological disease, and growing concern regarding long-term systemic medication use are creating a durable demand base. Neuromodulation can act directly on selected neural pathways and allows stimulation settings to be adjusted according to patient response, while intrathecal infusion delivers medication near the spinal cord and may support patients who receive insufficient relief or unacceptable adverse effects from oral therapy. Continued advances in stimulation waveforms, directional leads, miniaturized power systems and digital programming are expanding treatment beyond traditional refractory cases toward more precisely selected patient groups. The industry is consequently evolving from a standalone implant market into a long-term ecosystem combining implantation, programming, follow-up services and replacement components.
Because these products require surgical implantation and remain in the body for extended periods, adoption is influenced by patient selection, specialist availability, reimbursement and willingness to undergo an implant procedure. Infection, lead migration or fracture, premature battery depletion, declining therapeutic effect and discomfort at the implant site may require reprogramming, revision or additional surgery. Implantable infusion pumps introduce further risks involving catheter blockage, underdelivery or overdose, pump interruption and refill management. Rigorous regulatory review, long-term reliability testing and continuous adverse-event surveillance increase development and compliance costs, making manufacturing quality and post-market support essential to customer confidence.
Hospitals and physicians are moving beyond evaluating whether a system can generate stimulation and are focusing increasingly on whether it can provide durable, stable and manageable clinical outcomes. Demand is shifting toward smaller implants, longer operating life, lower charging burden, MRI compatibility and support for multiple therapy programs. Intelligent systems capable of sensing patient status, refining stimulation parameters and preserving treatment records will strengthen individualized care. Multidisciplinary collaboration among pain centers, neurosurgery, functional neurology, urology and rehabilitation departments is also increasing, making patient-selection support, physician training, programming services and long-term follow-up as influential as the device itself in purchasing decisions.
This report studies the global Neuromodulation Devices and Implantable Infusion Pumps production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Neuromodulation Devices and Implantable Infusion Pumps and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Neuromodulation Devices and Implantable Infusion Pumps that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Neuromodulation Devices and Implantable Infusion Pumps total production and demand, 2021-2032, (Unit)
Global Neuromodulation Devices and Implantable Infusion Pumps total production value, 2021-2032, (USD Million)
Global Neuromodulation Devices and Implantable Infusion Pumps production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Unit), (based on production site)
Global Neuromodulation Devices and Implantable Infusion Pumps consumption by region & country, CAGR, 2021-2032 & (Unit)
U.S. VS China: Neuromodulation Devices and Implantable Infusion Pumps domestic production, consumption, key domestic manufacturers and share
Global Neuromodulation Devices and Implantable Infusion Pumps production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Unit)
Global Neuromodulation Devices and Implantable Infusion Pumps production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Unit)
Global Neuromodulation Devices and Implantable Infusion Pumps production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Unit)
This report profiles key players in the global Neuromodulation Devices and Implantable Infusion Pumps market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Boston Scientific, Abbott, Nevro, LivaNova, Synapse Biomedical, Flowonix, Tricumed, PINS Medical, SceneRay, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Neuromodulation Devices and Implantable Infusion Pumps market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Unit) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Neuromodulation Devices and Implantable Infusion Pumps Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Neuromodulation Devices
- Implantable Infusion Pumps
- Pain Management
- Movement Disorder
- Spasticity
- Urinary and Bowel Dysfunction
- Other
- Rechargeable Implant
- Non-rechargeable Implant
- Chronic Pain Therapy
- Neurological Disease Management
- Intrathecal Drug Delivery
- Functional Neuromodulation
- Other
- Medtronic
- Boston Scientific
- Abbott
- Nevro
- LivaNova
- Synapse Biomedical
- Flowonix
- Tricumed
- PINS Medical
- SceneRay
- MicroPort
- Beijing Rishena
1. How big is the global Neuromodulation Devices and Implantable Infusion Pumps market?
2. What is the demand of the global Neuromodulation Devices and Implantable Infusion Pumps market?
3. What is the year over year growth of the global Neuromodulation Devices and Implantable Infusion Pumps market?
4. What is the production and production value of the global Neuromodulation Devices and Implantable Infusion Pumps market?
5. Who are the key producers in the global Neuromodulation Devices and Implantable Infusion Pumps market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Neuromodulation Devices and Implantable Infusion Pumps Introduction
1.2 World Neuromodulation Devices and Implantable Infusion Pumps Supply & Forecast
1.2.1 World Neuromodulation Devices and Implantable Infusion Pumps Production Value (2021 & 2025 & 2032)
1.2.2 World Neuromodulation Devices and Implantable Infusion Pumps Production (2021-2032)
1.2.3 World Neuromodulation Devices and Implantable Infusion Pumps Pricing Trends (2021-2032)
1.3 World Neuromodulation Devices and Implantable Infusion Pumps Production by Region (Based on Production Site)
1.3.1 World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Region (2021-2032)
1.3.2 World Neuromodulation Devices and Implantable Infusion Pumps Production by Region (2021-2032)
1.3.3 World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Region (2021-2032)
1.3.4 North America Neuromodulation Devices and Implantable Infusion Pumps Production (2021-2032)
1.3.5 Europe Neuromodulation Devices and Implantable Infusion Pumps Production (2021-2032)
1.3.6 China Neuromodulation Devices and Implantable Infusion Pumps Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Neuromodulation Devices and Implantable Infusion Pumps Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Neuromodulation Devices and Implantable Infusion Pumps Major Market Trends
2 DEMAND SUMMARY
2.1 World Neuromodulation Devices and Implantable Infusion Pumps Demand (2021-2032)
2.2 World Neuromodulation Devices and Implantable Infusion Pumps Consumption by Region
2.2.1 World Neuromodulation Devices and Implantable Infusion Pumps Consumption by Region (2021-2026)
2.2.2 World Neuromodulation Devices and Implantable Infusion Pumps Consumption Forecast by Region (2027-2032)
2.3 United States Neuromodulation Devices and Implantable Infusion Pumps Consumption (2021-2032)
2.4 China Neuromodulation Devices and Implantable Infusion Pumps Consumption (2021-2032)
2.5 Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption (2021-2032)
2.6 Japan Neuromodulation Devices and Implantable Infusion Pumps Consumption (2021-2032)
2.7 South Korea Neuromodulation Devices and Implantable Infusion Pumps Consumption (2021-2032)
2.8 ASEAN Neuromodulation Devices and Implantable Infusion Pumps Consumption (2021-2032)
2.9 India Neuromodulation Devices and Implantable Infusion Pumps Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Manufacturer (2021-2026)
3.2 World Neuromodulation Devices and Implantable Infusion Pumps Production by Manufacturer (2021-2026)
3.3 World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Manufacturer (2021-2026)
3.4 Neuromodulation Devices and Implantable Infusion Pumps Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Neuromodulation Devices and Implantable Infusion Pumps in 2025
3.5.3 Global Concentration Ratios (CR8) for Neuromodulation Devices and Implantable Infusion Pumps in 2025
3.6 Neuromodulation Devices and Implantable Infusion Pumps Market: Overall Company Footprint Analysis
3.6.1 Neuromodulation Devices and Implantable Infusion Pumps Market: Region Footprint
3.6.2 Neuromodulation Devices and Implantable Infusion Pumps Market: Company Product Type Footprint
3.6.3 Neuromodulation Devices and Implantable Infusion Pumps Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Neuromodulation Devices and Implantable Infusion Pumps Production Value Comparison
4.1.1 United States VS China: Neuromodulation Devices and Implantable Infusion Pumps Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Neuromodulation Devices and Implantable Infusion Pumps Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Neuromodulation Devices and Implantable Infusion Pumps Production Comparison
4.2.1 United States VS China: Neuromodulation Devices and Implantable Infusion Pumps Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Neuromodulation Devices and Implantable Infusion Pumps Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Neuromodulation Devices and Implantable Infusion Pumps Consumption Comparison
4.3.1 United States VS China: Neuromodulation Devices and Implantable Infusion Pumps Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Neuromodulation Devices and Implantable Infusion Pumps Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Neuromodulation Devices and Implantable Infusion Pumps Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production Value (2021-2026)
4.4.3 United States Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production (2021-2026)
4.5 China Based Neuromodulation Devices and Implantable Infusion Pumps Manufacturers and Market Share
4.5.1 China Based Neuromodulation Devices and Implantable Infusion Pumps Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production Value (2021-2026)
4.5.3 China Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production (2021-2026)
4.6 Rest of World Based Neuromodulation Devices and Implantable Infusion Pumps Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Neuromodulation Devices and Implantable Infusion Pumps Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Neuromodulation Devices and Implantable Infusion Pumps Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Neuromodulation Devices
5.2.2 Implantable Infusion Pumps
5.3 Market Segment by Type
5.3.1 World Neuromodulation Devices and Implantable Infusion Pumps Production by Type (2021-2032)
5.3.2 World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Type (2021-2032)
5.3.3 World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY TARGET ANATOMY
6.1 World Neuromodulation Devices and Implantable Infusion Pumps Market Size Overview by Target Anatomy: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Target Anatomy
6.2.1 Pain Management
6.2.2 Movement Disorder
6.2.3 Spasticity
6.2.4 Urinary and Bowel Dysfunction
6.2.5 Other
6.3 Market Segment by Target Anatomy
6.3.1 World Neuromodulation Devices and Implantable Infusion Pumps Production by Target Anatomy (2021-2032)
6.3.2 World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Target Anatomy (2021-2032)
6.3.3 World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Target Anatomy (2021-2032)
7 MARKET ANALYSIS BY IMPLANTABLE PUMP TYPE
7.1 World Neuromodulation Devices and Implantable Infusion Pumps Market Size Overview by Implantable Pump Type: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Implantable Pump Type
7.2.1 Rechargeable Implant
7.2.2 Non-rechargeable Implant
7.3 Market Segment by Implantable Pump Type
7.3.1 World Neuromodulation Devices and Implantable Infusion Pumps Production by Implantable Pump Type (2021-2032)
7.3.2 World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Implantable Pump Type (2021-2032)
7.3.3 World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Implantable Pump Type (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Neuromodulation Devices and Implantable Infusion Pumps Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Chronic Pain Therapy
8.2.2 Neurological Disease Management
8.2.3 Intrathecal Drug Delivery
8.2.4 Functional Neuromodulation
8.2.5 Other
8.3 Market Segment by Application
8.3.1 World Neuromodulation Devices and Implantable Infusion Pumps Production by Application (2021-2032)
8.3.2 World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Application (2021-2032)
8.3.3 World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Medtronic
9.1.1 Medtronic Details
9.1.2 Medtronic Major Business
9.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product and Services
9.1.4 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Medtronic Recent Developments/Updates
9.1.6 Medtronic Competitive Strengths & Weaknesses
9.2 Boston Scientific
9.2.1 Boston Scientific Details
9.2.2 Boston Scientific Major Business
9.2.3 Boston Scientific Neuromodulation Devices and Implantable Infusion Pumps Product and Services
9.2.4 Boston Scientific Neuromodulation Devices and Implantable Infusion Pumps Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Boston Scientific Recent Developments/Updates
9.2.6 Boston Scientific Competitive Strengths & Weaknesses
9.3 Abbott
9.3.1 Abbott Details
9.3.2 Abbott Major Business
9.3.3 Abbott Neuromodulation Devices and Implantable Infusion Pumps Product and Services
9.3.4 Abbott Neuromodulation Devices and Implantable Infusion Pumps Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Abbott Recent Developments/Updates
9.3.6 Abbott Competitive Strengths & Weaknesses
9.4 Nevro
9.4.1 Nevro Details
9.4.2 Nevro Major Business
9.4.3 Nevro Neuromodulation Devices and Implantable Infusion Pumps Product and Services
9.4.4 Nevro Neuromodulation Devices and Implantable Infusion Pumps Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Nevro Recent Developments/Updates
9.4.6 Nevro Competitive Strengths & Weaknesses
9.5 LivaNova
9.5.1 LivaNova Details
9.5.2 LivaNova Major Business
9.5.3 LivaNova Neuromodulation Devices and Implantable Infusion Pumps Product and Services
9.5.4 LivaNova Neuromodulation Devices and Implantable Infusion Pumps Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 LivaNova Recent Developments/Updates
9.5.6 LivaNova Competitive Strengths & Weaknesses
9.6 Synapse Biomedical
9.6.1 Synapse Biomedical Details
9.6.2 Synapse Biomedical Major Business
9.6.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product and Services
9.6.4 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Synapse Biomedical Recent Developments/Updates
9.6.6 Synapse Biomedical Competitive Strengths & Weaknesses
9.7 Flowonix
9.7.1 Flowonix Details
9.7.2 Flowonix Major Business
9.7.3 Flowonix Neuromodulation Devices and Implantable Infusion Pumps Product and Services
9.7.4 Flowonix Neuromodulation Devices and Implantable Infusion Pumps Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Flowonix Recent Developments/Updates
9.7.6 Flowonix Competitive Strengths & Weaknesses
9.8 Tricumed
9.8.1 Tricumed Details
9.8.2 Tricumed Major Business
9.8.3 Tricumed Neuromodulation Devices and Implantable Infusion Pumps Product and Services
9.8.4 Tricumed Neuromodulation Devices and Implantable Infusion Pumps Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Tricumed Recent Developments/Updates
9.8.6 Tricumed Competitive Strengths & Weaknesses
9.9 PINS Medical
9.9.1 PINS Medical Details
9.9.2 PINS Medical Major Business
9.9.3 PINS Medical Neuromodulation Devices and Implantable Infusion Pumps Product and Services
9.9.4 PINS Medical Neuromodulation Devices and Implantable Infusion Pumps Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 PINS Medical Recent Developments/Updates
9.9.6 PINS Medical Competitive Strengths & Weaknesses
9.10 SceneRay
9.10.1 SceneRay Details
9.10.2 SceneRay Major Business
9.10.3 SceneRay Neuromodulation Devices and Implantable Infusion Pumps Product and Services
9.10.4 SceneRay Neuromodulation Devices and Implantable Infusion Pumps Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 SceneRay Recent Developments/Updates
9.10.6 SceneRay Competitive Strengths & Weaknesses
9.11 MicroPort
9.11.1 MicroPort Details
9.11.2 MicroPort Major Business
9.11.3 MicroPort Neuromodulation Devices and Implantable Infusion Pumps Product and Services
9.11.4 MicroPort Neuromodulation Devices and Implantable Infusion Pumps Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 MicroPort Recent Developments/Updates
9.11.6 MicroPort Competitive Strengths & Weaknesses
9.12 Beijing Rishena
9.12.1 Beijing Rishena Details
9.12.2 Beijing Rishena Major Business
9.12.3 Beijing Rishena Neuromodulation Devices and Implantable Infusion Pumps Product and Services
9.12.4 Beijing Rishena Neuromodulation Devices and Implantable Infusion Pumps Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Beijing Rishena Recent Developments/Updates
9.12.6 Beijing Rishena Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Neuromodulation Devices and Implantable Infusion Pumps Industry Chain
10.2 Neuromodulation Devices and Implantable Infusion Pumps Upstream Analysis
10.2.1 Neuromodulation Devices and Implantable Infusion Pumps Core Raw Materials
10.2.2 Main Manufacturers of Neuromodulation Devices and Implantable Infusion Pumps Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Neuromodulation Devices and Implantable Infusion Pumps Production Mode
10.6 Neuromodulation Devices and Implantable Infusion Pumps Procurement Model
10.7 Neuromodulation Devices and Implantable Infusion Pumps Industry Sales Model and Sales Channels
10.7.1 Neuromodulation Devices and Implantable Infusion Pumps Sales Model
10.7.2 Neuromodulation Devices and Implantable Infusion Pumps Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Neuromodulation Devices and Implantable Infusion Pumps Introduction
1.2 World Neuromodulation Devices and Implantable Infusion Pumps Supply & Forecast
1.2.1 World Neuromodulation Devices and Implantable Infusion Pumps Production Value (2021 & 2025 & 2032)
1.2.2 World Neuromodulation Devices and Implantable Infusion Pumps Production (2021-2032)
1.2.3 World Neuromodulation Devices and Implantable Infusion Pumps Pricing Trends (2021-2032)
1.3 World Neuromodulation Devices and Implantable Infusion Pumps Production by Region (Based on Production Site)
1.3.1 World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Region (2021-2032)
1.3.2 World Neuromodulation Devices and Implantable Infusion Pumps Production by Region (2021-2032)
1.3.3 World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Region (2021-2032)
1.3.4 North America Neuromodulation Devices and Implantable Infusion Pumps Production (2021-2032)
1.3.5 Europe Neuromodulation Devices and Implantable Infusion Pumps Production (2021-2032)
1.3.6 China Neuromodulation Devices and Implantable Infusion Pumps Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Neuromodulation Devices and Implantable Infusion Pumps Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Neuromodulation Devices and Implantable Infusion Pumps Major Market Trends
2 DEMAND SUMMARY
2.1 World Neuromodulation Devices and Implantable Infusion Pumps Demand (2021-2032)
2.2 World Neuromodulation Devices and Implantable Infusion Pumps Consumption by Region
2.2.1 World Neuromodulation Devices and Implantable Infusion Pumps Consumption by Region (2021-2026)
2.2.2 World Neuromodulation Devices and Implantable Infusion Pumps Consumption Forecast by Region (2027-2032)
2.3 United States Neuromodulation Devices and Implantable Infusion Pumps Consumption (2021-2032)
2.4 China Neuromodulation Devices and Implantable Infusion Pumps Consumption (2021-2032)
2.5 Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption (2021-2032)
2.6 Japan Neuromodulation Devices and Implantable Infusion Pumps Consumption (2021-2032)
2.7 South Korea Neuromodulation Devices and Implantable Infusion Pumps Consumption (2021-2032)
2.8 ASEAN Neuromodulation Devices and Implantable Infusion Pumps Consumption (2021-2032)
2.9 India Neuromodulation Devices and Implantable Infusion Pumps Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Manufacturer (2021-2026)
3.2 World Neuromodulation Devices and Implantable Infusion Pumps Production by Manufacturer (2021-2026)
3.3 World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Manufacturer (2021-2026)
3.4 Neuromodulation Devices and Implantable Infusion Pumps Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Neuromodulation Devices and Implantable Infusion Pumps in 2025
3.5.3 Global Concentration Ratios (CR8) for Neuromodulation Devices and Implantable Infusion Pumps in 2025
3.6 Neuromodulation Devices and Implantable Infusion Pumps Market: Overall Company Footprint Analysis
3.6.1 Neuromodulation Devices and Implantable Infusion Pumps Market: Region Footprint
3.6.2 Neuromodulation Devices and Implantable Infusion Pumps Market: Company Product Type Footprint
3.6.3 Neuromodulation Devices and Implantable Infusion Pumps Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Neuromodulation Devices and Implantable Infusion Pumps Production Value Comparison
4.1.1 United States VS China: Neuromodulation Devices and Implantable Infusion Pumps Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Neuromodulation Devices and Implantable Infusion Pumps Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Neuromodulation Devices and Implantable Infusion Pumps Production Comparison
4.2.1 United States VS China: Neuromodulation Devices and Implantable Infusion Pumps Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Neuromodulation Devices and Implantable Infusion Pumps Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Neuromodulation Devices and Implantable Infusion Pumps Consumption Comparison
4.3.1 United States VS China: Neuromodulation Devices and Implantable Infusion Pumps Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Neuromodulation Devices and Implantable Infusion Pumps Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Neuromodulation Devices and Implantable Infusion Pumps Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production Value (2021-2026)
4.4.3 United States Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production (2021-2026)
4.5 China Based Neuromodulation Devices and Implantable Infusion Pumps Manufacturers and Market Share
4.5.1 China Based Neuromodulation Devices and Implantable Infusion Pumps Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production Value (2021-2026)
4.5.3 China Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production (2021-2026)
4.6 Rest of World Based Neuromodulation Devices and Implantable Infusion Pumps Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Neuromodulation Devices and Implantable Infusion Pumps Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Neuromodulation Devices and Implantable Infusion Pumps Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Neuromodulation Devices
5.2.2 Implantable Infusion Pumps
5.3 Market Segment by Type
5.3.1 World Neuromodulation Devices and Implantable Infusion Pumps Production by Type (2021-2032)
5.3.2 World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Type (2021-2032)
5.3.3 World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY TARGET ANATOMY
6.1 World Neuromodulation Devices and Implantable Infusion Pumps Market Size Overview by Target Anatomy: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Target Anatomy
6.2.1 Pain Management
6.2.2 Movement Disorder
6.2.3 Spasticity
6.2.4 Urinary and Bowel Dysfunction
6.2.5 Other
6.3 Market Segment by Target Anatomy
6.3.1 World Neuromodulation Devices and Implantable Infusion Pumps Production by Target Anatomy (2021-2032)
6.3.2 World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Target Anatomy (2021-2032)
6.3.3 World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Target Anatomy (2021-2032)
7 MARKET ANALYSIS BY IMPLANTABLE PUMP TYPE
7.1 World Neuromodulation Devices and Implantable Infusion Pumps Market Size Overview by Implantable Pump Type: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Implantable Pump Type
7.2.1 Rechargeable Implant
7.2.2 Non-rechargeable Implant
7.3 Market Segment by Implantable Pump Type
7.3.1 World Neuromodulation Devices and Implantable Infusion Pumps Production by Implantable Pump Type (2021-2032)
7.3.2 World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Implantable Pump Type (2021-2032)
7.3.3 World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Implantable Pump Type (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Neuromodulation Devices and Implantable Infusion Pumps Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Chronic Pain Therapy
8.2.2 Neurological Disease Management
8.2.3 Intrathecal Drug Delivery
8.2.4 Functional Neuromodulation
8.2.5 Other
8.3 Market Segment by Application
8.3.1 World Neuromodulation Devices and Implantable Infusion Pumps Production by Application (2021-2032)
8.3.2 World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Application (2021-2032)
8.3.3 World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Medtronic
9.1.1 Medtronic Details
9.1.2 Medtronic Major Business
9.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product and Services
9.1.4 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Medtronic Recent Developments/Updates
9.1.6 Medtronic Competitive Strengths & Weaknesses
9.2 Boston Scientific
9.2.1 Boston Scientific Details
9.2.2 Boston Scientific Major Business
9.2.3 Boston Scientific Neuromodulation Devices and Implantable Infusion Pumps Product and Services
9.2.4 Boston Scientific Neuromodulation Devices and Implantable Infusion Pumps Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Boston Scientific Recent Developments/Updates
9.2.6 Boston Scientific Competitive Strengths & Weaknesses
9.3 Abbott
9.3.1 Abbott Details
9.3.2 Abbott Major Business
9.3.3 Abbott Neuromodulation Devices and Implantable Infusion Pumps Product and Services
9.3.4 Abbott Neuromodulation Devices and Implantable Infusion Pumps Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Abbott Recent Developments/Updates
9.3.6 Abbott Competitive Strengths & Weaknesses
9.4 Nevro
9.4.1 Nevro Details
9.4.2 Nevro Major Business
9.4.3 Nevro Neuromodulation Devices and Implantable Infusion Pumps Product and Services
9.4.4 Nevro Neuromodulation Devices and Implantable Infusion Pumps Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Nevro Recent Developments/Updates
9.4.6 Nevro Competitive Strengths & Weaknesses
9.5 LivaNova
9.5.1 LivaNova Details
9.5.2 LivaNova Major Business
9.5.3 LivaNova Neuromodulation Devices and Implantable Infusion Pumps Product and Services
9.5.4 LivaNova Neuromodulation Devices and Implantable Infusion Pumps Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 LivaNova Recent Developments/Updates
9.5.6 LivaNova Competitive Strengths & Weaknesses
9.6 Synapse Biomedical
9.6.1 Synapse Biomedical Details
9.6.2 Synapse Biomedical Major Business
9.6.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product and Services
9.6.4 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Synapse Biomedical Recent Developments/Updates
9.6.6 Synapse Biomedical Competitive Strengths & Weaknesses
9.7 Flowonix
9.7.1 Flowonix Details
9.7.2 Flowonix Major Business
9.7.3 Flowonix Neuromodulation Devices and Implantable Infusion Pumps Product and Services
9.7.4 Flowonix Neuromodulation Devices and Implantable Infusion Pumps Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Flowonix Recent Developments/Updates
9.7.6 Flowonix Competitive Strengths & Weaknesses
9.8 Tricumed
9.8.1 Tricumed Details
9.8.2 Tricumed Major Business
9.8.3 Tricumed Neuromodulation Devices and Implantable Infusion Pumps Product and Services
9.8.4 Tricumed Neuromodulation Devices and Implantable Infusion Pumps Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Tricumed Recent Developments/Updates
9.8.6 Tricumed Competitive Strengths & Weaknesses
9.9 PINS Medical
9.9.1 PINS Medical Details
9.9.2 PINS Medical Major Business
9.9.3 PINS Medical Neuromodulation Devices and Implantable Infusion Pumps Product and Services
9.9.4 PINS Medical Neuromodulation Devices and Implantable Infusion Pumps Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 PINS Medical Recent Developments/Updates
9.9.6 PINS Medical Competitive Strengths & Weaknesses
9.10 SceneRay
9.10.1 SceneRay Details
9.10.2 SceneRay Major Business
9.10.3 SceneRay Neuromodulation Devices and Implantable Infusion Pumps Product and Services
9.10.4 SceneRay Neuromodulation Devices and Implantable Infusion Pumps Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 SceneRay Recent Developments/Updates
9.10.6 SceneRay Competitive Strengths & Weaknesses
9.11 MicroPort
9.11.1 MicroPort Details
9.11.2 MicroPort Major Business
9.11.3 MicroPort Neuromodulation Devices and Implantable Infusion Pumps Product and Services
9.11.4 MicroPort Neuromodulation Devices and Implantable Infusion Pumps Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 MicroPort Recent Developments/Updates
9.11.6 MicroPort Competitive Strengths & Weaknesses
9.12 Beijing Rishena
9.12.1 Beijing Rishena Details
9.12.2 Beijing Rishena Major Business
9.12.3 Beijing Rishena Neuromodulation Devices and Implantable Infusion Pumps Product and Services
9.12.4 Beijing Rishena Neuromodulation Devices and Implantable Infusion Pumps Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Beijing Rishena Recent Developments/Updates
9.12.6 Beijing Rishena Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Neuromodulation Devices and Implantable Infusion Pumps Industry Chain
10.2 Neuromodulation Devices and Implantable Infusion Pumps Upstream Analysis
10.2.1 Neuromodulation Devices and Implantable Infusion Pumps Core Raw Materials
10.2.2 Main Manufacturers of Neuromodulation Devices and Implantable Infusion Pumps Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Neuromodulation Devices and Implantable Infusion Pumps Production Mode
10.6 Neuromodulation Devices and Implantable Infusion Pumps Procurement Model
10.7 Neuromodulation Devices and Implantable Infusion Pumps Industry Sales Model and Sales Channels
10.7.1 Neuromodulation Devices and Implantable Infusion Pumps Sales Model
10.7.2 Neuromodulation Devices and Implantable Infusion Pumps Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Region (2021-2026) & (USD Million)
Table 3. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Region (2027-2032) & (USD Million)
Table 4. World Neuromodulation Devices and Implantable Infusion Pumps Production Value Market Share by Region (2021-2026)
Table 5. World Neuromodulation Devices and Implantable Infusion Pumps Production Value Market Share by Region (2027-2032)
Table 6. World Neuromodulation Devices and Implantable Infusion Pumps Production by Region (2021-2026) & (Unit)
Table 7. World Neuromodulation Devices and Implantable Infusion Pumps Production by Region (2027-2032) & (Unit)
Table 8. World Neuromodulation Devices and Implantable Infusion Pumps Production Market Share by Region (2021-2026)
Table 9. World Neuromodulation Devices and Implantable Infusion Pumps Production Market Share by Region (2027-2032)
Table 10. World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Region (2021-2026) & (USD/Unit)
Table 11. World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Region (2027-2032) & (USD/Unit)
Table 12. Neuromodulation Devices and Implantable Infusion Pumps Major Market Trends
Table 13. World Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Unit)
Table 14. World Neuromodulation Devices and Implantable Infusion Pumps Consumption by Region (2021-2026) & (Unit)
Table 15. World Neuromodulation Devices and Implantable Infusion Pumps Consumption Forecast by Region (2027-2032) & (Unit)
Table 16. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Neuromodulation Devices and Implantable Infusion Pumps Producers in 2025
Table 18. World Neuromodulation Devices and Implantable Infusion Pumps Production by Manufacturer (2021-2026) & (Unit)
Table 19. Production Market Share of Key Neuromodulation Devices and Implantable Infusion Pumps Producers in 2025
Table 20. World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Manufacturer (2021-2026) & (USD/Unit)
Table 21. Global Neuromodulation Devices and Implantable Infusion Pumps Company Evaluation Quadrant
Table 22. World Neuromodulation Devices and Implantable Infusion Pumps Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Neuromodulation Devices and Implantable Infusion Pumps Production Site of Key Manufacturer
Table 24. Neuromodulation Devices and Implantable Infusion Pumps Market: Company Product Type Footprint
Table 25. Neuromodulation Devices and Implantable Infusion Pumps Market: Company Product Application Footprint
Table 26. Neuromodulation Devices and Implantable Infusion Pumps Competitive Factors
Table 27. Neuromodulation Devices and Implantable Infusion Pumps New Entrant and Capacity Expansion Plans
Table 28. Neuromodulation Devices and Implantable Infusion Pumps Mergers & Acquisitions Activity
Table 29. United States VS China Neuromodulation Devices and Implantable Infusion Pumps Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Neuromodulation Devices and Implantable Infusion Pumps Production Comparison, (2021 & 2025 & 2032) & (Unit)
Table 31. United States VS China Neuromodulation Devices and Implantable Infusion Pumps Consumption Comparison, (2021 & 2025 & 2032) & (Unit)
Table 32. United States Based Neuromodulation Devices and Implantable Infusion Pumps Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production (2021-2026) & (Unit)
Table 36. United States Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production Market Share (2021-2026)
Table 37. China Based Neuromodulation Devices and Implantable Infusion Pumps Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production, (2021-2026) & (Unit)
Table 41. China Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production Market Share (2021-2026)
Table 42. Rest of World Based Neuromodulation Devices and Implantable Infusion Pumps Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production, (2021-2026) & (Unit)
Table 46. Rest of World Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production Market Share (2021-2026)
Table 47. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Neuromodulation Devices and Implantable Infusion Pumps Production by Type (2021-2026) & (Unit)
Table 49. World Neuromodulation Devices and Implantable Infusion Pumps Production by Type (2027-2032) & (Unit)
Table 50. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Type (2021-2026) & (USD Million)
Table 51. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Type (2027-2032) & (USD Million)
Table 52. World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Type (2021-2026) & (USD/Unit)
Table 53. World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Type (2027-2032) & (USD/Unit)
Table 54. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Target Anatomy, (USD Million), 2021 & 2025 & 2032
Table 55. World Neuromodulation Devices and Implantable Infusion Pumps Production by Target Anatomy (2021-2026) & (Unit)
Table 56. World Neuromodulation Devices and Implantable Infusion Pumps Production by Target Anatomy (2027-2032) & (Unit)
Table 57. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Target Anatomy (2021-2026) & (USD Million)
Table 58. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Target Anatomy (2027-2032) & (USD Million)
Table 59. World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Target Anatomy (2021-2026) & (USD/Unit)
Table 60. World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Target Anatomy (2027-2032) & (USD/Unit)
Table 61. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Implantable Pump Type, (USD Million), 2021 & 2025 & 2032
Table 62. World Neuromodulation Devices and Implantable Infusion Pumps Production by Implantable Pump Type (2021-2026) & (Unit)
Table 63. World Neuromodulation Devices and Implantable Infusion Pumps Production by Implantable Pump Type (2027-2032) & (Unit)
Table 64. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Implantable Pump Type (2021-2026) & (USD Million)
Table 65. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Implantable Pump Type (2027-2032) & (USD Million)
Table 66. World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Implantable Pump Type (2021-2026) & (USD/Unit)
Table 67. World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Implantable Pump Type (2027-2032) & (USD/Unit)
Table 68. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Neuromodulation Devices and Implantable Infusion Pumps Production by Application (2021-2026) & (Unit)
Table 70. World Neuromodulation Devices and Implantable Infusion Pumps Production by Application (2027-2032) & (Unit)
Table 71. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Application (2021-2026) & (USD Million)
Table 72. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Application (2027-2032) & (USD Million)
Table 73. World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Application (2021-2026) & (USD/Unit)
Table 74. World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Application (2027-2032) & (USD/Unit)
Table 75. Medtronic Basic Information, Manufacturing Base and Competitors
Table 76. Medtronic Major Business
Table 77. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 78. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Production (Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Medtronic Recent Developments/Updates
Table 80. Medtronic Competitive Strengths & Weaknesses
Table 81. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 82. Boston Scientific Major Business
Table 83. Boston Scientific Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 84. Boston Scientific Neuromodulation Devices and Implantable Infusion Pumps Production (Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Boston Scientific Recent Developments/Updates
Table 86. Boston Scientific Competitive Strengths & Weaknesses
Table 87. Abbott Basic Information, Manufacturing Base and Competitors
Table 88. Abbott Major Business
Table 89. Abbott Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 90. Abbott Neuromodulation Devices and Implantable Infusion Pumps Production (Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Abbott Recent Developments/Updates
Table 92. Abbott Competitive Strengths & Weaknesses
Table 93. Nevro Basic Information, Manufacturing Base and Competitors
Table 94. Nevro Major Business
Table 95. Nevro Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 96. Nevro Neuromodulation Devices and Implantable Infusion Pumps Production (Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Nevro Recent Developments/Updates
Table 98. Nevro Competitive Strengths & Weaknesses
Table 99. LivaNova Basic Information, Manufacturing Base and Competitors
Table 100. LivaNova Major Business
Table 101. LivaNova Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 102. LivaNova Neuromodulation Devices and Implantable Infusion Pumps Production (Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. LivaNova Recent Developments/Updates
Table 104. LivaNova Competitive Strengths & Weaknesses
Table 105. Synapse Biomedical Basic Information, Manufacturing Base and Competitors
Table 106. Synapse Biomedical Major Business
Table 107. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 108. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Production (Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Synapse Biomedical Recent Developments/Updates
Table 110. Synapse Biomedical Competitive Strengths & Weaknesses
Table 111. Flowonix Basic Information, Manufacturing Base and Competitors
Table 112. Flowonix Major Business
Table 113. Flowonix Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 114. Flowonix Neuromodulation Devices and Implantable Infusion Pumps Production (Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Flowonix Recent Developments/Updates
Table 116. Flowonix Competitive Strengths & Weaknesses
Table 117. Tricumed Basic Information, Manufacturing Base and Competitors
Table 118. Tricumed Major Business
Table 119. Tricumed Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 120. Tricumed Neuromodulation Devices and Implantable Infusion Pumps Production (Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Tricumed Recent Developments/Updates
Table 122. Tricumed Competitive Strengths & Weaknesses
Table 123. PINS Medical Basic Information, Manufacturing Base and Competitors
Table 124. PINS Medical Major Business
Table 125. PINS Medical Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 126. PINS Medical Neuromodulation Devices and Implantable Infusion Pumps Production (Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. PINS Medical Recent Developments/Updates
Table 128. PINS Medical Competitive Strengths & Weaknesses
Table 129. SceneRay Basic Information, Manufacturing Base and Competitors
Table 130. SceneRay Major Business
Table 131. SceneRay Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 132. SceneRay Neuromodulation Devices and Implantable Infusion Pumps Production (Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. SceneRay Recent Developments/Updates
Table 134. SceneRay Competitive Strengths & Weaknesses
Table 135. MicroPort Basic Information, Manufacturing Base and Competitors
Table 136. MicroPort Major Business
Table 137. MicroPort Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 138. MicroPort Neuromodulation Devices and Implantable Infusion Pumps Production (Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. MicroPort Recent Developments/Updates
Table 140. MicroPort Competitive Strengths & Weaknesses
Table 141. Beijing Rishena Basic Information, Manufacturing Base and Competitors
Table 142. Beijing Rishena Major Business
Table 143. Beijing Rishena Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 144. Beijing Rishena Neuromodulation Devices and Implantable Infusion Pumps Production (Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Beijing Rishena Recent Developments/Updates
Table 146. Beijing Rishena Competitive Strengths & Weaknesses
Table 147. Global Key Players of Neuromodulation Devices and Implantable Infusion Pumps Upstream (Raw Materials)
Table 148. Global Neuromodulation Devices and Implantable Infusion Pumps Typical Customers
Table 149. Neuromodulation Devices and Implantable Infusion Pumps Typical Distributors
Table 1. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Region (2021-2026) & (USD Million)
Table 3. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Region (2027-2032) & (USD Million)
Table 4. World Neuromodulation Devices and Implantable Infusion Pumps Production Value Market Share by Region (2021-2026)
Table 5. World Neuromodulation Devices and Implantable Infusion Pumps Production Value Market Share by Region (2027-2032)
Table 6. World Neuromodulation Devices and Implantable Infusion Pumps Production by Region (2021-2026) & (Unit)
Table 7. World Neuromodulation Devices and Implantable Infusion Pumps Production by Region (2027-2032) & (Unit)
Table 8. World Neuromodulation Devices and Implantable Infusion Pumps Production Market Share by Region (2021-2026)
Table 9. World Neuromodulation Devices and Implantable Infusion Pumps Production Market Share by Region (2027-2032)
Table 10. World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Region (2021-2026) & (USD/Unit)
Table 11. World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Region (2027-2032) & (USD/Unit)
Table 12. Neuromodulation Devices and Implantable Infusion Pumps Major Market Trends
Table 13. World Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Unit)
Table 14. World Neuromodulation Devices and Implantable Infusion Pumps Consumption by Region (2021-2026) & (Unit)
Table 15. World Neuromodulation Devices and Implantable Infusion Pumps Consumption Forecast by Region (2027-2032) & (Unit)
Table 16. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Neuromodulation Devices and Implantable Infusion Pumps Producers in 2025
Table 18. World Neuromodulation Devices and Implantable Infusion Pumps Production by Manufacturer (2021-2026) & (Unit)
Table 19. Production Market Share of Key Neuromodulation Devices and Implantable Infusion Pumps Producers in 2025
Table 20. World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Manufacturer (2021-2026) & (USD/Unit)
Table 21. Global Neuromodulation Devices and Implantable Infusion Pumps Company Evaluation Quadrant
Table 22. World Neuromodulation Devices and Implantable Infusion Pumps Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Neuromodulation Devices and Implantable Infusion Pumps Production Site of Key Manufacturer
Table 24. Neuromodulation Devices and Implantable Infusion Pumps Market: Company Product Type Footprint
Table 25. Neuromodulation Devices and Implantable Infusion Pumps Market: Company Product Application Footprint
Table 26. Neuromodulation Devices and Implantable Infusion Pumps Competitive Factors
Table 27. Neuromodulation Devices and Implantable Infusion Pumps New Entrant and Capacity Expansion Plans
Table 28. Neuromodulation Devices and Implantable Infusion Pumps Mergers & Acquisitions Activity
Table 29. United States VS China Neuromodulation Devices and Implantable Infusion Pumps Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Neuromodulation Devices and Implantable Infusion Pumps Production Comparison, (2021 & 2025 & 2032) & (Unit)
Table 31. United States VS China Neuromodulation Devices and Implantable Infusion Pumps Consumption Comparison, (2021 & 2025 & 2032) & (Unit)
Table 32. United States Based Neuromodulation Devices and Implantable Infusion Pumps Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production (2021-2026) & (Unit)
Table 36. United States Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production Market Share (2021-2026)
Table 37. China Based Neuromodulation Devices and Implantable Infusion Pumps Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production, (2021-2026) & (Unit)
Table 41. China Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production Market Share (2021-2026)
Table 42. Rest of World Based Neuromodulation Devices and Implantable Infusion Pumps Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production, (2021-2026) & (Unit)
Table 46. Rest of World Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production Market Share (2021-2026)
Table 47. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Neuromodulation Devices and Implantable Infusion Pumps Production by Type (2021-2026) & (Unit)
Table 49. World Neuromodulation Devices and Implantable Infusion Pumps Production by Type (2027-2032) & (Unit)
Table 50. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Type (2021-2026) & (USD Million)
Table 51. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Type (2027-2032) & (USD Million)
Table 52. World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Type (2021-2026) & (USD/Unit)
Table 53. World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Type (2027-2032) & (USD/Unit)
Table 54. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Target Anatomy, (USD Million), 2021 & 2025 & 2032
Table 55. World Neuromodulation Devices and Implantable Infusion Pumps Production by Target Anatomy (2021-2026) & (Unit)
Table 56. World Neuromodulation Devices and Implantable Infusion Pumps Production by Target Anatomy (2027-2032) & (Unit)
Table 57. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Target Anatomy (2021-2026) & (USD Million)
Table 58. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Target Anatomy (2027-2032) & (USD Million)
Table 59. World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Target Anatomy (2021-2026) & (USD/Unit)
Table 60. World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Target Anatomy (2027-2032) & (USD/Unit)
Table 61. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Implantable Pump Type, (USD Million), 2021 & 2025 & 2032
Table 62. World Neuromodulation Devices and Implantable Infusion Pumps Production by Implantable Pump Type (2021-2026) & (Unit)
Table 63. World Neuromodulation Devices and Implantable Infusion Pumps Production by Implantable Pump Type (2027-2032) & (Unit)
Table 64. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Implantable Pump Type (2021-2026) & (USD Million)
Table 65. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Implantable Pump Type (2027-2032) & (USD Million)
Table 66. World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Implantable Pump Type (2021-2026) & (USD/Unit)
Table 67. World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Implantable Pump Type (2027-2032) & (USD/Unit)
Table 68. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Neuromodulation Devices and Implantable Infusion Pumps Production by Application (2021-2026) & (Unit)
Table 70. World Neuromodulation Devices and Implantable Infusion Pumps Production by Application (2027-2032) & (Unit)
Table 71. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Application (2021-2026) & (USD Million)
Table 72. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Application (2027-2032) & (USD Million)
Table 73. World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Application (2021-2026) & (USD/Unit)
Table 74. World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Application (2027-2032) & (USD/Unit)
Table 75. Medtronic Basic Information, Manufacturing Base and Competitors
Table 76. Medtronic Major Business
Table 77. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 78. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Production (Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Medtronic Recent Developments/Updates
Table 80. Medtronic Competitive Strengths & Weaknesses
Table 81. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 82. Boston Scientific Major Business
Table 83. Boston Scientific Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 84. Boston Scientific Neuromodulation Devices and Implantable Infusion Pumps Production (Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Boston Scientific Recent Developments/Updates
Table 86. Boston Scientific Competitive Strengths & Weaknesses
Table 87. Abbott Basic Information, Manufacturing Base and Competitors
Table 88. Abbott Major Business
Table 89. Abbott Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 90. Abbott Neuromodulation Devices and Implantable Infusion Pumps Production (Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Abbott Recent Developments/Updates
Table 92. Abbott Competitive Strengths & Weaknesses
Table 93. Nevro Basic Information, Manufacturing Base and Competitors
Table 94. Nevro Major Business
Table 95. Nevro Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 96. Nevro Neuromodulation Devices and Implantable Infusion Pumps Production (Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Nevro Recent Developments/Updates
Table 98. Nevro Competitive Strengths & Weaknesses
Table 99. LivaNova Basic Information, Manufacturing Base and Competitors
Table 100. LivaNova Major Business
Table 101. LivaNova Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 102. LivaNova Neuromodulation Devices and Implantable Infusion Pumps Production (Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. LivaNova Recent Developments/Updates
Table 104. LivaNova Competitive Strengths & Weaknesses
Table 105. Synapse Biomedical Basic Information, Manufacturing Base and Competitors
Table 106. Synapse Biomedical Major Business
Table 107. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 108. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Production (Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Synapse Biomedical Recent Developments/Updates
Table 110. Synapse Biomedical Competitive Strengths & Weaknesses
Table 111. Flowonix Basic Information, Manufacturing Base and Competitors
Table 112. Flowonix Major Business
Table 113. Flowonix Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 114. Flowonix Neuromodulation Devices and Implantable Infusion Pumps Production (Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Flowonix Recent Developments/Updates
Table 116. Flowonix Competitive Strengths & Weaknesses
Table 117. Tricumed Basic Information, Manufacturing Base and Competitors
Table 118. Tricumed Major Business
Table 119. Tricumed Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 120. Tricumed Neuromodulation Devices and Implantable Infusion Pumps Production (Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Tricumed Recent Developments/Updates
Table 122. Tricumed Competitive Strengths & Weaknesses
Table 123. PINS Medical Basic Information, Manufacturing Base and Competitors
Table 124. PINS Medical Major Business
Table 125. PINS Medical Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 126. PINS Medical Neuromodulation Devices and Implantable Infusion Pumps Production (Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. PINS Medical Recent Developments/Updates
Table 128. PINS Medical Competitive Strengths & Weaknesses
Table 129. SceneRay Basic Information, Manufacturing Base and Competitors
Table 130. SceneRay Major Business
Table 131. SceneRay Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 132. SceneRay Neuromodulation Devices and Implantable Infusion Pumps Production (Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. SceneRay Recent Developments/Updates
Table 134. SceneRay Competitive Strengths & Weaknesses
Table 135. MicroPort Basic Information, Manufacturing Base and Competitors
Table 136. MicroPort Major Business
Table 137. MicroPort Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 138. MicroPort Neuromodulation Devices and Implantable Infusion Pumps Production (Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. MicroPort Recent Developments/Updates
Table 140. MicroPort Competitive Strengths & Weaknesses
Table 141. Beijing Rishena Basic Information, Manufacturing Base and Competitors
Table 142. Beijing Rishena Major Business
Table 143. Beijing Rishena Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 144. Beijing Rishena Neuromodulation Devices and Implantable Infusion Pumps Production (Unit), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Beijing Rishena Recent Developments/Updates
Table 146. Beijing Rishena Competitive Strengths & Weaknesses
Table 147. Global Key Players of Neuromodulation Devices and Implantable Infusion Pumps Upstream (Raw Materials)
Table 148. Global Neuromodulation Devices and Implantable Infusion Pumps Typical Customers
Table 149. Neuromodulation Devices and Implantable Infusion Pumps Typical Distributors
LIST OF FIGURES
Figure 1. Neuromodulation Devices and Implantable Infusion Pumps Picture
Figure 2. World Neuromodulation Devices and Implantable Infusion Pumps Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Neuromodulation Devices and Implantable Infusion Pumps Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Neuromodulation Devices and Implantable Infusion Pumps Production (2021-2032) & (Unit)
Figure 5. World Neuromodulation Devices and Implantable Infusion Pumps Average Price (2021-2032) & (USD/Unit)
Figure 6. World Neuromodulation Devices and Implantable Infusion Pumps Production Value Market Share by Region (2021-2032)
Figure 7. World Neuromodulation Devices and Implantable Infusion Pumps Production Market Share by Region (2021-2032)
Figure 8. North America Neuromodulation Devices and Implantable Infusion Pumps Production (2021-2032) & (Unit)
Figure 9. Europe Neuromodulation Devices and Implantable Infusion Pumps Production (2021-2032) & (Unit)
Figure 10. China Neuromodulation Devices and Implantable Infusion Pumps Production (2021-2032) & (Unit)
Figure 11. Neuromodulation Devices and Implantable Infusion Pumps Market Drivers
Figure 12. Factors Affecting Demand
Figure 13. World Neuromodulation Devices and Implantable Infusion Pumps Consumption (2021-2032) & (Unit)
Figure 14. World Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Region (2021-2032)
Figure 15. United States Neuromodulation Devices and Implantable Infusion Pumps Consumption (2021-2032) & (Unit)
Figure 16. China Neuromodulation Devices and Implantable Infusion Pumps Consumption (2021-2032) & (Unit)
Figure 17. Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption (2021-2032) & (Unit)
Figure 18. Japan Neuromodulation Devices and Implantable Infusion Pumps Consumption (2021-2032) & (Unit)
Figure 19. South Korea Neuromodulation Devices and Implantable Infusion Pumps Consumption (2021-2032) & (Unit)
Figure 20. ASEAN Neuromodulation Devices and Implantable Infusion Pumps Consumption (2021-2032) & (Unit)
Figure 21. India Neuromodulation Devices and Implantable Infusion Pumps Consumption (2021-2032) & (Unit)
Figure 22. Producer Shipments of Neuromodulation Devices and Implantable Infusion Pumps by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 23. Global Four-firm Concentration Ratios (CR4) for Neuromodulation Devices and Implantable Infusion Pumps Markets in 2025
Figure 24. Global Four-firm Concentration Ratios (CR8) for Neuromodulation Devices and Implantable Infusion Pumps Markets in 2025
Figure 25. United States VS China: Neuromodulation Devices and Implantable Infusion Pumps Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 26. United States VS China: Neuromodulation Devices and Implantable Infusion Pumps Production Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production Market Share 2025
Figure 29. China Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production Market Share 2025
Figure 30. Rest of World Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production Market Share 2025
Figure 31. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 32. World Neuromodulation Devices and Implantable Infusion Pumps Production Value Market Share by Type in 2025
Figure 33. Neuromodulation Devices
Figure 34. Implantable Infusion Pumps
Figure 35. World Neuromodulation Devices and Implantable Infusion Pumps Production Market Share by Type (2021-2032)
Figure 36. World Neuromodulation Devices and Implantable Infusion Pumps Production Value Market Share by Type (2021-2032)
Figure 37. World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Type (2021-2032) & (USD/Unit)
Figure 38. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Target Anatomy, (USD Million), 2021 & 2025 & 2032
Figure 39. World Neuromodulation Devices and Implantable Infusion Pumps Production Value Market Share by Target Anatomy in 2025
Figure 40. Pain Management
Figure 41. Movement Disorder
Figure 42. Spasticity
Figure 43. Urinary and Bowel Dysfunction
Figure 44. Other
Figure 45. World Neuromodulation Devices and Implantable Infusion Pumps Production Market Share by Target Anatomy (2021-2032)
Figure 46. World Neuromodulation Devices and Implantable Infusion Pumps Production Value Market Share by Target Anatomy (2021-2032)
Figure 47. World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Target Anatomy (2021-2032) & (USD/Unit)
Figure 48. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Implantable Pump Type, (USD Million), 2021 & 2025 & 2032
Figure 49. World Neuromodulation Devices and Implantable Infusion Pumps Production Value Market Share by Implantable Pump Type in 2025
Figure 50. Rechargeable Implant
Figure 51. Non-rechargeable Implant
Figure 52. World Neuromodulation Devices and Implantable Infusion Pumps Production Market Share by Implantable Pump Type (2021-2032)
Figure 53. World Neuromodulation Devices and Implantable Infusion Pumps Production Value Market Share by Implantable Pump Type (2021-2032)
Figure 54. World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Implantable Pump Type (2021-2032) & (USD/Unit)
Figure 55. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 56. World Neuromodulation Devices and Implantable Infusion Pumps Production Value Market Share by Application in 2025
Figure 57. Chronic Pain Therapy
Figure 58. Neurological Disease Management
Figure 59. Intrathecal Drug Delivery
Figure 60. Functional Neuromodulation
Figure 61. Other
Figure 62. World Neuromodulation Devices and Implantable Infusion Pumps Production Market Share by Application (2021-2032)
Figure 63. World Neuromodulation Devices and Implantable Infusion Pumps Production Value Market Share by Application (2021-2032)
Figure 64. World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Application (2021-2032) & (USD/Unit)
Figure 65. Neuromodulation Devices and Implantable Infusion Pumps Industry Chain
Figure 66. Neuromodulation Devices and Implantable Infusion Pumps Procurement Model
Figure 67. Neuromodulation Devices and Implantable Infusion Pumps Sales Model
Figure 68. Neuromodulation Devices and Implantable Infusion Pumps Sales Channels, Direct Sales, and Distribution
Figure 69. Methodology
Figure 70. Research Process and Data Source
Figure 1. Neuromodulation Devices and Implantable Infusion Pumps Picture
Figure 2. World Neuromodulation Devices and Implantable Infusion Pumps Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Neuromodulation Devices and Implantable Infusion Pumps Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Neuromodulation Devices and Implantable Infusion Pumps Production (2021-2032) & (Unit)
Figure 5. World Neuromodulation Devices and Implantable Infusion Pumps Average Price (2021-2032) & (USD/Unit)
Figure 6. World Neuromodulation Devices and Implantable Infusion Pumps Production Value Market Share by Region (2021-2032)
Figure 7. World Neuromodulation Devices and Implantable Infusion Pumps Production Market Share by Region (2021-2032)
Figure 8. North America Neuromodulation Devices and Implantable Infusion Pumps Production (2021-2032) & (Unit)
Figure 9. Europe Neuromodulation Devices and Implantable Infusion Pumps Production (2021-2032) & (Unit)
Figure 10. China Neuromodulation Devices and Implantable Infusion Pumps Production (2021-2032) & (Unit)
Figure 11. Neuromodulation Devices and Implantable Infusion Pumps Market Drivers
Figure 12. Factors Affecting Demand
Figure 13. World Neuromodulation Devices and Implantable Infusion Pumps Consumption (2021-2032) & (Unit)
Figure 14. World Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Region (2021-2032)
Figure 15. United States Neuromodulation Devices and Implantable Infusion Pumps Consumption (2021-2032) & (Unit)
Figure 16. China Neuromodulation Devices and Implantable Infusion Pumps Consumption (2021-2032) & (Unit)
Figure 17. Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption (2021-2032) & (Unit)
Figure 18. Japan Neuromodulation Devices and Implantable Infusion Pumps Consumption (2021-2032) & (Unit)
Figure 19. South Korea Neuromodulation Devices and Implantable Infusion Pumps Consumption (2021-2032) & (Unit)
Figure 20. ASEAN Neuromodulation Devices and Implantable Infusion Pumps Consumption (2021-2032) & (Unit)
Figure 21. India Neuromodulation Devices and Implantable Infusion Pumps Consumption (2021-2032) & (Unit)
Figure 22. Producer Shipments of Neuromodulation Devices and Implantable Infusion Pumps by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 23. Global Four-firm Concentration Ratios (CR4) for Neuromodulation Devices and Implantable Infusion Pumps Markets in 2025
Figure 24. Global Four-firm Concentration Ratios (CR8) for Neuromodulation Devices and Implantable Infusion Pumps Markets in 2025
Figure 25. United States VS China: Neuromodulation Devices and Implantable Infusion Pumps Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 26. United States VS China: Neuromodulation Devices and Implantable Infusion Pumps Production Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production Market Share 2025
Figure 29. China Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production Market Share 2025
Figure 30. Rest of World Based Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Production Market Share 2025
Figure 31. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 32. World Neuromodulation Devices and Implantable Infusion Pumps Production Value Market Share by Type in 2025
Figure 33. Neuromodulation Devices
Figure 34. Implantable Infusion Pumps
Figure 35. World Neuromodulation Devices and Implantable Infusion Pumps Production Market Share by Type (2021-2032)
Figure 36. World Neuromodulation Devices and Implantable Infusion Pumps Production Value Market Share by Type (2021-2032)
Figure 37. World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Type (2021-2032) & (USD/Unit)
Figure 38. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Target Anatomy, (USD Million), 2021 & 2025 & 2032
Figure 39. World Neuromodulation Devices and Implantable Infusion Pumps Production Value Market Share by Target Anatomy in 2025
Figure 40. Pain Management
Figure 41. Movement Disorder
Figure 42. Spasticity
Figure 43. Urinary and Bowel Dysfunction
Figure 44. Other
Figure 45. World Neuromodulation Devices and Implantable Infusion Pumps Production Market Share by Target Anatomy (2021-2032)
Figure 46. World Neuromodulation Devices and Implantable Infusion Pumps Production Value Market Share by Target Anatomy (2021-2032)
Figure 47. World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Target Anatomy (2021-2032) & (USD/Unit)
Figure 48. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Implantable Pump Type, (USD Million), 2021 & 2025 & 2032
Figure 49. World Neuromodulation Devices and Implantable Infusion Pumps Production Value Market Share by Implantable Pump Type in 2025
Figure 50. Rechargeable Implant
Figure 51. Non-rechargeable Implant
Figure 52. World Neuromodulation Devices and Implantable Infusion Pumps Production Market Share by Implantable Pump Type (2021-2032)
Figure 53. World Neuromodulation Devices and Implantable Infusion Pumps Production Value Market Share by Implantable Pump Type (2021-2032)
Figure 54. World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Implantable Pump Type (2021-2032) & (USD/Unit)
Figure 55. World Neuromodulation Devices and Implantable Infusion Pumps Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 56. World Neuromodulation Devices and Implantable Infusion Pumps Production Value Market Share by Application in 2025
Figure 57. Chronic Pain Therapy
Figure 58. Neurological Disease Management
Figure 59. Intrathecal Drug Delivery
Figure 60. Functional Neuromodulation
Figure 61. Other
Figure 62. World Neuromodulation Devices and Implantable Infusion Pumps Production Market Share by Application (2021-2032)
Figure 63. World Neuromodulation Devices and Implantable Infusion Pumps Production Value Market Share by Application (2021-2032)
Figure 64. World Neuromodulation Devices and Implantable Infusion Pumps Average Price by Application (2021-2032) & (USD/Unit)
Figure 65. Neuromodulation Devices and Implantable Infusion Pumps Industry Chain
Figure 66. Neuromodulation Devices and Implantable Infusion Pumps Procurement Model
Figure 67. Neuromodulation Devices and Implantable Infusion Pumps Sales Model
Figure 68. Neuromodulation Devices and Implantable Infusion Pumps Sales Channels, Direct Sales, and Distribution
Figure 69. Methodology
Figure 70. Research Process and Data Source
